Adjunctive Hormone Testing When Measuring Testosterone in Males
When drawing testosterone levels in males, additional hormone testing should be performed selectively based on clinical presentation and initial testosterone results, with luteinizing hormone (LH) measurement being essential for all patients with low testosterone, while estradiol should only be measured when breast symptoms or gynecomastia are present. 1
Essential Hormone Testing Algorithm
For All Males with Low Testosterone:
- Luteinizing Hormone (LH) - Mandatory for all patients with low testosterone 1
- Helps establish the etiology of testosterone deficiency (primary vs. secondary)
- Guides further diagnostic workup
- Identifies candidates for selective estrogen receptor modulator therapy
Based on LH Results:
- If LH is low or low/normal with low testosterone:
Selective Testing Based on Symptoms:
Estradiol - Only measure when patient presents with:
- Breast symptoms
- Gynecomastia
- Before starting testosterone therapy in patients with these symptoms 1
Follicle-Stimulating Hormone (FSH) - Only measure when:
- Patient expresses interest in fertility
- Preservation of reproductive health is a concern 1
Clinical Implications and Rationale
The American Urological Association provides strong evidence (Grade A) for measuring LH in all patients with low testosterone, as this helps distinguish between primary testicular failure and hypothalamic-pituitary disorders 1. This distinction is crucial for determining appropriate treatment pathways and identifying underlying conditions requiring further evaluation.
Measuring estradiol is not routinely necessary but becomes important when breast symptoms are present, as elevated estradiol may require endocrinology referral 1. Testosterone therapy can increase estradiol levels through aromatization, potentially worsening gynecomastia in susceptible individuals.
For men concerned about fertility, FSH measurement provides valuable information about spermatogenesis status, with elevated levels suggesting impaired sperm production 1.
Common Pitfalls to Avoid
Overordering hormone panels - Comprehensive "female hormone panels" are unnecessary for most male patients with suspected testosterone deficiency and add cost without clinical benefit
Neglecting LH measurement - Failing to measure LH in men with low testosterone misses the opportunity to properly classify hypogonadism as primary or secondary
Relying solely on testosterone levels - Testosterone levels alone, without appropriate adjunctive testing, may lead to misdiagnosis or inappropriate treatment
Missing pituitary pathology - Patients with severely low testosterone (<150 ng/dL) and low/normal LH should undergo pituitary imaging regardless of prolactin levels 1
By following this targeted approach to hormone testing in males with suspected testosterone deficiency, clinicians can efficiently diagnose the underlying cause while avoiding unnecessary testing, ultimately improving patient outcomes through appropriate treatment selection.